Power injectable port identification

Information

  • Patent Grant
  • 8075536
  • Patent Number
    8,075,536
  • Date Filed
    Tuesday, September 9, 2008
    16 years ago
  • Date Issued
    Tuesday, December 13, 2011
    12 years ago
Abstract
An implantable port for accessing internal body structures, the port comprises a proximal housing including an opening providing access to an interior of the port and a distal housing adapted for assembly with the proximal housing, the distal housing including a reservoir which, when the distal housing is mated with the proximal housing is in fluid communication with the opening of the proximal housing in combination with a radiopaque element in one of the proximal and distal housings, a shape of the radiopaque element identifying, when imaged, a structural characteristic of the port not otherwise identifiable visually.
Description
BACKGROUND

Implantable ports are designed for patients who require long term access to the central venous system or other internal structures for the administration and/or withdrawal of fluids, including hydration fluids, antibiotics, chemotherapy, analgesics, nutritional therapy and blood products. A catheter is typically inserted to form a path to the vascular system by advancing a distal end of the catheter into a blood vessel while a proximal end is connected to the port that is implanted subcutaneously. The port is generally placed under the skin on the upper part of the chest wall or the upper arm, and allows patients to access the desired body lumen while avoiding repeated needlesticks to the target structure. Power injectable implantable ports offer the additional advantage of providing access for the power injection of contrast agents to enhance imaging, such as Contrast-Enhanced Computer Tomography (CECT) scans, which rely on intravenously administered contrast agents to enhance the visibility of internal structures. The contrast agent is power injected into the blood stream to highlight features that would otherwise be difficult to distinguish from nearby tissues. Thus, power injectable ports provide access for the standard injection and withdrawal of fluids (e.g., for therapeutic purposes) and for power injection of contrast agents to enhance imaging.


Although, it is desirable to use ports which are also suitable for power injection, users must be able to positively identify such ports to ensure they are not accessing a port which is not useable for power injection. The industry has established a “CT” mark, which when viewed under a CT scan, is a standard indication of power injectability. Some existing “CT” identifying technologies known in the field today include a cut-through “CT” design through the port body. The limitation of this design is the space available on the port that would allow for adequate size and visibility of the “CT” lettering. Another disadvantage of cut-through design is that the space could promote tissue ingrowth, which may make it more difficult to remove the port later.


Pad printing the “CT” letters onto the port using radiopaque ink is another existing technology. Radiopaque ink prevents X-rays or similar radiation waves to pass therethrough so that they may be identified in scans. However, the radiopaque ink in these ports is often located on an outer surface of the port, which can be susceptible to damage such as smearing, cracking and fragmenting in the subcutaneous environment, making the marking unreadable. In addition, fragments of ink may migrate, leading to ink integrity issues.


Another CT identifying technology is used in the POWERPORT®, manufactured by Bard Access Systems Inc., Salt Lake City, Utah. The POWERPORT® includes an external metal component with “CT” lettering at the base. However, the “CT” lettering occupies a space on the base of the port where the device labeling is typically placed. Device labeling may include manufacturer and/or lot numbers, which may be helpful in identifying the port. In addition, there is a risk of the external component becoming separated from the device.


SUMMARY OF THE INVENTION

The present invention is directed to an implantable port for accessing internal body structures, the port comprises a proximal housing including an opening providing access to an interior of the port and a distal housing adapted for assembly with the proximal housing, the distal housing including a reservoir which, when the distal housing is mated with the proximal housing is in fluid communication with the opening of the proximal housing in combination with a radiopaque element in one of the proximal and distal housings, a shape of the radiopaque element identifying, when imaged, a structural characteristic of the port not otherwise identifiable visually.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 shows a port according to an exemplary embodiment the invention;



FIG. 2 shows a cross-sectional view of a distal housing of the port of FIG. 1;



FIG. 3 shows a cross-sectional view of a port according to another embodiment of the invention;



FIG. 4 shows an exploded view of the port of FIG. 3;



FIG. 5 shows an exploded bottom view of a port according to another embodiment of the invention; and



FIG. 6 shows an exploded view of a port according to yet another embodiment of the invention.





DETAILED DESCRIPTION

The present invention may be further understood with reference to the following description of exemplary embodiments and the related appended drawings, wherein like elements are provided with the same reference numerals. The present invention relates to devices for accessing the vascular system via a catheter and, more specifically, relates to a power-injectable port that may be identified as such after implantation. Those skilled in the art will understand that the ports described herein are generally implanted with an opening through which fluids are to be introduced or withdrawn facing the skin. As used in this application, the term proximal refers to a direction toward the skin while distal refers to a distance deeper into the body.


As shown in FIGS. 1 and 2, a port 10 according to an exemplary embodiment the invention comprises a distal housing 12 and a proximal housing 14 which are mated together to seal an internal reservoir 16 coupled to a fluid outlet 18 which is coupled to a body structure to which fluids are to be supplied and/or from which fluids are to be withdrawn. A proximal surface of the proximal housing 14 includes an opening 20 via which fluids are supplied and/or withdrawn from the reservoir 16. The opening 20 is sealed by a self-sealing septum 22. Thus, the reservoir and the body structure to which the outlet 18 is coupled may be accessed by passing a needle through the septum 22 with the septum 22 resealing itself as soon as the needle is withdrawn, as would be understood by those skilled in the art.


As shown in FIG. 2, a radiopaque insert 24 is embedded in a base 26 of the distal housing 12. The radiopaque insert 24 incorporates an identifying mark 28 (e.g., a CT mark or other indication of characteristics of the port) visible through the use of one or more types of electromagnetic scan such as X-rays, etc. As would be understood by those skilled in the art, the radiopaque insert 24 may be formed of any material having the desired radiopaque properties (e.g., titanium). The identifying mark 28 may, for example, be cut-through the radiopaque insert 24 allowing the scanning radiation to pass therethrough in a pattern indicative of a characteristic (e.g., suitability for power injection) of the port 10. Those skilled in the art will understand that, as the insert 24 is embedded in the distal housing 12, the cut-through design of the identifying mark 28 will be clearly visible without increasing the likelihood of tissue ingrowth. The CT mark shown in FIG. 2 is for illustrative purposes only, and it will be understood by those of skill in the art that a CT mark on the radiopaque insert 24 may be a mirror image of the marking shown so that the CT may be legible when viewed under the electromagnetic scan.


As would be understood by those skilled in the art, the radiopaque insert 24 may be embedded within distal housing 12 via an insert molding process in which the radiopaque insert 24 is robotically or hand loaded into a mold cavity between shots. The insert 24 is supported in position in the mold by a series of needle-like core pins and, during injection, these pins are retracted into the mold base as the plastic fills the cavity and encapsulates the insert. Once the insert 24 has been embedded in the distal housing 12, the distal housing 12 is ready to be assembled with the other port components in the same manner for a port without such a radiopaque insert 24. Standard assembly techniques such as ultrasonic welding, snap fit or solvent bond may be utilized as would be understood by those skilled in the art.


As shown in FIGS. 3 and 4, a port 30 according to another embodiment of the invention comprises a distal housing 32, a proximal housing 34 and a radiopaque insert 36. The distal housing 32 includes a distal flange 38 extending radially outward from a wall of 40 of the distal housing forming a reservoir of the port 30 with a corresponding proximal flange 42 of the proximal housing 34 extending thereover when assembled with the distal housing 32. The proximal housing 34 is preferably formed so that, when mated with the distal housing 32, a recess 44 is formed between the distal and proximal flanges 38, 42, respectively. The radiopaque insert 36 is received in the recess 44 between the distal and proximal flanges 38, 42, respectively. The distal housing 32 and the proximal housing 34 may then be joined via any standard plastic joining process, such as ultrasonic welding, snap-fit, and solvent bond, to hold the radiopaque insert 36 in place as would be understood by those skilled in the art.


As described above, the radiopaque insert 36 may be made of any radiopaque material with an identifying mark 46 (e.g., CT) cut-out so that the mark 46 is clearly visible when imaged using any of the known scanning techniques. As the insert 36 is housed between the proximal and distal flanges 38, 42, respectively, the cut-out poses no risk of tissue ingrowth and the risk of the insert 36 becoming detached from the port 30 is also minimized.


In a further embodiment of the present invention, the radiopaque insert 36 may be embedded in either of the proximal and distal flanges 38, 42, respectively using an insert molding process. As described above, the radiopaque insert 36 may be placed into a mold cavity between shots and held in place by a series of needle-like core pins. During injection, these pins are retracted into the mold base as plastic fills the cavity and encapsulates the insert 36. Once the insert 36 has been embedded, the distal housing 32 is ready to be assembled with the other port components including the proximal housing 34 as described above.


In another embodiment of the present invention, as shown in FIG. 5, a port 50 comprises a distal housing 52 and a radiopaque insert 54 having a periphery shaped to define an identifying mark 56. Those skilled in the art will understand that, when the identifying mark consists of more than one element (e.g., multiple letters) a minimal amount of radiopaque material may extend between these elements to maintain a desired alignment during the molding process. The insert 54 may be overmolded into the distal housing 52 by inserting it into the cavity before injection. The plastic would form around the insert, leaving the surface of the CT mark visible on the underside of the base. The distal housing 52 with overmolded radiopaque insert 54 may be assembled with the rest of the port components using any standard assembly techniques as described above.


In a further embodiment, the overmolded insert 54 may be mechanically combined with a port stem and inserted into the mold. Overmolding would then encapsulate and seal the insert 54 into the distal housing 52 while simultaneously binding the stem to the distal housing 52. Such an embodiment provides a radiopaque marker for power injectability while eliminating a separate stem/port assembly step.


In another embodiment of the present invention, shown in FIG. 6, a port 60 comprises a proximal housing 62 that may be molded using plastic loaded with radiopaque fillers such as barium, bismuth, and tungsten. The proximal housing 62 includes a proximal flange 64 extending radially outward therefrom with a corresponding distal flange 68 extending radially outward from a distal housing 70 in the same manner described above in regard to the port 30 of FIGS. 3 and 4. The proximal flange 64 includes an identifying mark 72 mark cut through a thickness thereof (e.g., during a molding process). The distal housing 70, or at least the distal flange 68, is formed of standard plastic with no radiopaque fillers so that the mark 72 creates a “negative” of the mark 72 when imaged (e.g., under CT or other body scan). In order to prevent tissue ingrowth, a silicone boot or skirt may be incorporated such that the boot or skirt covers the cut-through lettering. It will be understood by those of skill in the art that the boot or skirt may additionally be composed of any suitable non-radiopaque material. Furthermore, those skilled in the art will understand that the distal housing 70 may, alternatively, be formed of a material incorporating radiopaque fillers with the mark 72 cut out of the distal flange 68 while the proximal housing 64 is formed of a material free of radiopaque fillers.


It will be apparent to those skilled in the art that various modifications and variations can be made in the structure and the methodology of the present invention, without departing from the spirit or scope of the invention. Thus, it is intended that the present invention cover the modifications and variations of this invention provided that they come within the scope of the appended claims and their equivalents.

Claims
  • 1. An implantable port for accessing internal body structures, the port comprising: a proximal housing including an opening providing access to an interior of the port;a distal housing adapted for assembly with the proximal housing, the distal housing including a reservoir which, when the distal housing is mated with the proximal housing is in fluid communication with the opening of the proximal housing, wherein the distal housing includes a first flange extending radially outward from a wall thereof forming the reservoir and wherein the proximal housing includes a second flange extending radially outward and corresponding to the first flange, the second flange being sized to cover the first flange when the distal and proximal housings are mated with one another to form the port, and wherein the first and second flanges are formed so that, when the distal and proximal housings are mated with one another to form the port, a recess is formed between a proximal surface of the first flange and a distal surface of the second flange and wherein a radiopaque element is received in the recess; andthe radiopaque element in one of the proximal and distal housings, the radiopaque element identifying, when imaged, a characteristic of the port not otherwise visually identifiable after implantation within a living body.
  • 2. The port of claim 1, wherein one of the first and second flanges is formed of a material including a radiopaque filler and the other of the first and second flanges is formed of a material transparent to an imaging radiation and wherein the one of the first and second flanges formed of a material including a radiopaque filler includes a cut-out shaped to identify the structural characteristic of the port.
  • 3. The port of claim 2, wherein the one of the first and second flanges formed of a material including a radiopaque filler includes a covering member to prevent tissue ingrowth into the cut-out.
  • 4. The port of claim 1, wherein the radiopaque element is molded into the first flange.
  • 5. The port of claim 1, wherein the radiopaque element is molded into a portion of the distal housing forming a distal wall of the reservoir.
  • 6. The port of claim 5, wherein the radiopaque element is overmolded on the distal housing so that the radiopaque element is visible as a part of a distal surface of the port.
  • 7. The port of claim 6, wherein a periphery of the radiopaque element is shaped to identify the structural characteristic of the port.
  • 8. The port of claim 6, wherein an interior cut-out of the radiopaque element is shaped to identify the structural characteristic of the port.
  • 9. The port of claim 1, wherein the radiopaque element includes a cut-through.
  • 10. The port of claim 9, wherein the cut-through indicates that the port is suitable for power injection.
  • 11. The port of claim 10, wherein the cut-through is in the shape of CT.
  • 12. The port of claim 1, wherein the radiopaque element is embedded in one of the proximal and distal housings.
  • 13. The port of claim 12, wherein the radiopaque element is embedded using an insert molding process.
  • 14. The port of claim 13, wherein the radiopaque element is embedded in the distal housing.
  • 15. The port of claim 12, wherein an outlet stem of the port is overmolded to one of the proximal and distal housings when the radiopaque element is embedded.
  • 16. The port of claim 1, wherein the radiopaque element is overmolded into the distal housing such that identifying information of the radiopaque element is visible on a bottom surface of the distal housing.
  • 17. The port of claim 16, wherein the radiopaque element is coupled to an outlet stem prior to being overmolded into the distal housing.
  • 18. The port of claim 1, wherein the distal housing is assembled with the proximal housing using one of an ultrasonic welding process, a snap fit mechanism, and a solvent bond.
  • 19. The port of claim 1, wherein the radiopaque element includes titanium.
US Referenced Citations (121)
Number Name Date Kind
3159175 Macmillan Dec 1964 A
3477438 Allen et al. Nov 1969 A
3525357 Koreski Aug 1970 A
3541438 Nelsen et al. Nov 1970 A
3669323 Harker et al. Jun 1972 A
3674183 Venable et al. Jul 1972 A
3811466 Ohringer May 1974 A
3853127 Spademan Dec 1974 A
3955594 Snow May 1976 A
3971376 Wichterle Jul 1976 A
4143853 Abramson Mar 1979 A
4447237 Frisch et al. May 1984 A
4543088 Bootman et al. Sep 1985 A
4610665 Matsumoto et al. Sep 1986 A
4692146 Hilger Sep 1987 A
4772270 Waiita et al. Sep 1988 A
4781680 Redmond et al. Nov 1988 A
4802885 Weeks et al. Feb 1989 A
4857053 Dalton Aug 1989 A
4886501 Johnston et al. Dec 1989 A
4886502 Poirier et al. Dec 1989 A
4892518 Cupp et al. Jan 1990 A
4897081 Poirier et al. Jan 1990 A
4904241 Bark Feb 1990 A
4908029 Bark et al. Mar 1990 A
4929236 Sampson May 1990 A
5009391 Steigerwald Apr 1991 A
5009644 McDonald Apr 1991 A
5045060 Melsky et al. Sep 1991 A
5053013 Ensminger et al. Oct 1991 A
5059186 Yamamoto et al. Oct 1991 A
5069206 Crosbie Dec 1991 A
5084015 Moriuchi Jan 1992 A
5092849 Sampson Mar 1992 A
5129891 Young Jul 1992 A
5137529 Watson et al. Aug 1992 A
5147483 Melsky et al. Sep 1992 A
5167638 Felix et al. Dec 1992 A
5180365 Ensminger et al. Jan 1993 A
5205834 Moorehead et al. Apr 1993 A
5242415 Kantrowitz et al. Sep 1993 A
5249598 Schmidt Oct 1993 A
5263930 Ensminger Nov 1993 A
5281199 Ensminger et al. Jan 1994 A
5312337 Flaherty et al. May 1994 A
5318545 Tucker Jun 1994 A
5350360 Ensminger et al. Sep 1994 A
5352204 Ensminger Oct 1994 A
5356381 Ensminger et al. Oct 1994 A
5387192 Glantz et al. Feb 1995 A
5396925 Poli et al. Mar 1995 A
5399168 Wadsworth, Jr. et al. Mar 1995 A
5417656 Ensminger et al. May 1995 A
5423334 Jordan Jun 1995 A
5453097 Paradis Sep 1995 A
5476451 Ensminger et al. Dec 1995 A
5520643 Ensminger et al. May 1996 A
5527277 Ensminger et al. Jun 1996 A
5527278 Ensminger et al. Jun 1996 A
5531684 Ensminger et al. Jul 1996 A
5542923 Ensminger et al. Aug 1996 A
5554117 Ensminger et al. Sep 1996 A
5556381 Ensminger et al. Sep 1996 A
5558641 Glantz et al. Sep 1996 A
5562618 Cai et al. Oct 1996 A
5607393 Ensminger et al. Mar 1997 A
5613945 Cai et al. Mar 1997 A
RE35601 Eckenhoff Sep 1997 E
5662616 Bousquet Sep 1997 A
5707357 Mikhail et al. Jan 1998 A
5741228 Lambrecht et al. Apr 1998 A
5755780 Finch et al. May 1998 A
5792104 Speckman et al. Aug 1998 A
5792123 Ensminger Aug 1998 A
5797886 Roth et al. Aug 1998 A
5814016 Valley et al. Sep 1998 A
5848989 Villani Dec 1998 A
5879322 Lattin et al. Mar 1999 A
5882341 Bousquet Mar 1999 A
5897528 Schultz Apr 1999 A
5906596 Tallarida May 1999 A
5911706 Estabrook et al. Jun 1999 A
5941856 Kovacs et al. Aug 1999 A
5944688 Lois Aug 1999 A
5944698 Fischer et al. Aug 1999 A
5954687 Baudino Sep 1999 A
5954691 Prosl Sep 1999 A
5961497 Larkin Oct 1999 A
5989216 Johnson et al. Nov 1999 A
6056717 Finch et al. May 2000 A
6086555 Eliasen et al. Jul 2000 A
6099508 Bousquet Aug 2000 A
6152909 Bagaoisan et al. Nov 2000 A
6210366 Sanfilippo Apr 2001 B1
6287293 Jones et al. Sep 2001 B1
6306124 Jones et al. Oct 2001 B1
6527754 Tallarida et al. Mar 2003 B1
6592571 Verbeek et al. Jul 2003 B1
6610031 Chin Aug 2003 B1
6726063 Stull et al. Apr 2004 B2
6962577 Tallarida et al. Nov 2005 B2
7033339 Lynn Apr 2006 B1
20010016717 Haarala et al. Aug 2001 A1
20010056266 Tallarida et al. Dec 2001 A1
20020013557 Sherry Jan 2002 A1
20020121530 Socier Sep 2002 A1
20030109856 Sherry Jun 2003 A1
20030141477 Miller Jul 2003 A1
20030216694 Tollini Nov 2003 A1
20040133173 Edoga et al. Jul 2004 A1
20040186444 Daly et al. Sep 2004 A1
20050010176 Dikeman et al. Jan 2005 A1
20050027234 Waggoner et al. Feb 2005 A1
20050027261 Weaver et al. Feb 2005 A1
20050080401 Peavey Apr 2005 A1
20060178647 Stats Aug 2006 A1
20060224129 Beasley et al. Oct 2006 A1
20060247584 Sheetz et al. Nov 2006 A1
20070078391 Wortley et al. Apr 2007 A1
20070100302 DiCarlo et al. May 2007 A1
20070233017 Zinn et al. Oct 2007 A1
Foreign Referenced Citations (20)
Number Date Country
0128525 Dec 1984 EP
0343910 Nov 1989 EP
0366814 May 1990 EP
2508008 Dec 1982 FR
2809315 Nov 2001 FR
0966137 Aug 1964 GB
2102398 Feb 1983 GB
WO-9206732 Apr 1992 WO
WO-9405351 Mar 1994 WO
WO-9516480 Jun 1995 WO
WO-9701370 Jan 1997 WO
WO-9723255 Jul 1997 WO
WO-9726931 Jul 1997 WO
WO-9818506 Aug 1997 WO
WO-0012171 Mar 2000 WO
WO-0016844 Mar 2000 WO
WO-0033901 Jun 2000 WO
WO-0160444 Aug 2001 WO
WO-03084832 Oct 2003 WO
WO-2005068009 Jul 2005 WO
Related Publications (1)
Number Date Country
20100063451 A1 Mar 2010 US